Clinical Trials
71 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Qurgen Inc.
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
STILVARCA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
PITHAC
Centre Hospitalier Universitaire Vaudois
VUBAR
Universitair Ziekenhuis Brussel
Family History Study on Cancer Risk
Kaiser Permanente
OPTI-DOSE
University Medical Center Groningen
UPLIFT
Massachusetts General Hospital
IMX-110 in Patients With Advanced Solid Tumors
Immix Biopharma, Inc.
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Namida Lab
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
THE EFFECT OF CANCER EDUCATION ON WOMEN'S AWARENESS LEVELS AND THEIR BEHAVIORS ON SCREENINGS
Ankara Yildirim Beyazıt University
ELISA
Assistance Publique - Hôpitaux de Paris
CADENCE
MiRXES Pte Ltd
Gen-eva
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
WEE1
Impact Therapeutics, Inc.
Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients
China Medical University Hospital
Endometrial Changes in Breast Cancer Women.
Regina Elena Cancer Institute
FIT2
Charite University, Berlin, Germany
RESTORE
Blue Note Therapeutics
Coala-T-CBD
Main Line Health
MICROBIOME
Imperial College London
A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors
Silverback Therapeutics
PASSION
Assistance Publique - Hôpitaux de Paris
The Effect of the Motivational Interviewing Technique on Breast and Cervical Cancer Screenings
Istanbul Saglik Bilimleri University
SPACE2
Weprom
Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
YSCH-01
Shanghai Fengxian District Central Hospital
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
University Hospital Southampton NHS Foundation Trust
PIONEER
SpeciCare
Cryotherapy vs. Cryocompression for Preventing Chemotherapy-induced-peripheral-neuropathy in Women Undergoing Chemotherapy
Medical University Innsbruck
GALENO 1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Guided Imagery & Music in Cancer
Aalborg University
A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
Petra Pharma
Study to Evaluate the Safety of Nanoxel M Inj.
Samyang Biopharmaceuticals Corporation
Laser Fluorescence in Cancer Surgical Treatment
Instituto do Cancer do Estado de São Paulo
Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer
The University of The West Indies
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations
Placon Therapeutics
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells
Xuanwu Hospital, Beijing
Circulating Tumor DNA Exposure in Peripheral Blood
Quantgene Inc.
Women's Knowledges About Gynaecological Aftercare
University Hospital, Strasbourg, France
E3N
Institut National de la Santé Et de la Recherche Médicale, France
Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors
Poveda, Andrés, M.D.
OPTIMISE-1
Heidelberg University
Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy
SPGO Research Mannheim GmbH
Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans
Rigshospitalet, Denmark